ARTICLE | Clinical News
Annexin V-128: Phase II started
September 12, 2016 7:00 AM UTC
Advanced Accelerator began an open-label, Canadian Phase II trial to evaluate 99mTc-rhAnnexin V-128 followed by cardiac MRI and left ventricular nuclear scans in about 30 patients with early stage bre...